RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Klose, Karl E.
PropertyValue
overview Dr. Klose’s lab is interested in bacterial pathogenesis -- how bacteria cause disease. Dr. Klose has worked most extensively with Vibrio cholerae, the bacterium that causes cholera, and is also researching Francisella tularensis, the bacterium that causes tularemia, or rabbit fever. Cholera is found only where there are widespread problems with sanitation, so improving water and food supplies would eliminate the disease. Since that is unlikely to occur, a safe, cheap, effective vaccine is needed that would protect people. To design such a vaccine, the lab is addressing questions such as: How does V. cholerae know that it is in a human body and that is the place to express genes necessary for its survival and disease potential? What are the genetic factors responsible for V. cholerae to cause disease? How does this organism persist in aquatic environments, which lead to human infection? Very little is known about F. tularensis or about tularemia. It is a highly virulent organism and can easily be aerosolized, so it is classified by the Centers for Disease Control (CDC) as a Category A select agent with the highest potential to be used as a biological weapon. The lab is working to identify genetic factors responsible for F. tularensis to cause disease and to develop suitable vaccine candidates to protect against tularemia infection.
One or more keywords matched the following items that are connected to Klose, Karl E.
Item TypeName
Academic Article Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice.
Academic Article The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence.
Academic Article The Fischer 344 rat reflects human susceptibility to francisella pulmonary challenge and provides a new platform for virulence and protection studies.
Academic Article Mast cell/IL-4 control of Francisella tularensis replication and host cell death is associated with increased ATP production and phagosomal acidification.
Academic Article Tryptophan prototrophy contributes to Francisella tularensis evasion of gamma interferon-mediated host defense.
Academic Article Evasion of IFN-? signaling by Francisella novicida is dependent upon Francisella outer membrane protein C.
Academic Article Francisella DnaK inhibits tissue-nonspecific alkaline phosphatase.
Academic Article Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ?fopC vaccine strain.
Academic Article Mast cell TLR2 signaling is crucial for effective killing of Francisella tularensis.
Academic Article Mucosal immunization with live attenuated Francisella novicida U112?iglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model.
Academic Article Enhancement of vaccine efficacy by expression of a TLR5 ligand in the defined live attenuated Francisella tularensis subsp. novicida strain U112?iglB::fljB.
Academic Article Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates.
Academic Article Lipidation of the FPI protein IglE contributes to Francisella tularensis ssp. novicida intramacrophage replication and virulence.
Academic Article Comparative Transcriptional Analyses of Francisella tularensis and Francisella novicida.
Academic Article M-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensis.
Academic Article Allelic exchange in Francisella tularensis using PCR products.
Academic Article Molecular and genetic basis of pathogenesis in Francisella tularensis.
Academic Article Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection.
Academic Article Francisella tularensis travels a novel, twisted road within macrophages.
Academic Article Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.
Academic Article Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4.
Academic Article Characterization of the Francisella tularensis subsp. novicida type IV pilus.
Academic Article The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression.
Academic Article Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.
Academic Article Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.
Academic Article A Francisella tularensis pathogenicity island protein essential for bacterial proliferation within the host cell cytosol.
Academic Article The presence of infectious extracellular Francisella tularensis subsp. novicida in murine plasma after pulmonary challenge.
Academic Article CD4+ T cells are required during priming but not the effector phase of antibody-mediated IFN-gamma-dependent protective immunity against pulmonary Francisella novicida infection.
Concept Tularemia
Search Criteria
  • Tularemia
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support